Headlands Technologies »

Bioxcel Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 26k 1.41

More positions owned by Headlands Technologies

Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Cme (CME)
Intel Corporation (INTC)
O'reilly Automotive (ORLY)
Bloom Energy Corp Com Cl A (BE)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Interactive Brokers Group In Com Cl A (IBKR)
Oracle Corporation (ORCL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wal-Mart Stores (WMT)
Hldgs (UAL)
CSX Corporation (CSX)

View all positions for Headlands Technologies

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
Vanguard Capital Management
Oaktree Fund Advisors
Geode Capital Management
BlackRock
UBS Group
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
FMR
Wiley Bros.-aintree Capital
Jones Financial Companies, L.L
Northern Trust
HighTower Advisors

View all funds holding Bioxcel Therapeutics